Scientific background of hormonal treatment of prostate cancer.
Klijn
J G
JG
Division of Endocrine Oncology, Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
D002455:Cell Division / Q000502:physiology; D002869:Chromosome Aberrations / Q000235:genetics; D025063:Chromosome Disorders; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D006728:Hormones / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D009857:Oncogenes / Q000235:genetics; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D015291:Transforming Growth Factors / Q000096:biosynthesis / Q000502:physiology
D006728:Hormones; D015291:Transforming Growth Factors